Labeling is based on the agency's thorough analysis of the new drug application (NDA) or biological license application. The labeling, or prescribing information, is thus subject to FDA ...
On-going Phase 2b clinical trial (ELPIS II) deemed pivotal and, if positive, acceptable for Biological License Application (BLA) submission for potential full traditional approval ・Alignment with FDA ...
Biochemists in industry are interested in specific applications that will lead to marketable products Biochemists in academia or government labs conduct more basic and less applied research ...
The U.S. Food and Drug Administration (FDA) has approved two Octapharma supplements to Biological License Applications, strengthening the company's pediatric critical care product portfolio.
The Department of Biological Sciences treats the life sciences in all their breadth and diversity, including the study of molecules, cells, whole organisms, ecosystems, plants, animals and ...
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to ...
The Department of Chemical and Biological Engineering in the McCormick School of Engineering and Applied Science at Northwestern University has two primary goals: to train students to be leaders in ...
2006 Voluntarily at any time a Includes new drug applications, biological license applications, and efficacy supplements.
Researchers in the School of Biological Sciences conduct cutting-edge research ... We strongly encourage all applicants to contact an academic supervisor before starting their application. Scroll down ...
On-going Phase 2b clinical trial (ELPIS II) deemed pivotal and, if positive, acceptable for Biological License Application (BLA) submission for potential full traditional approval Alignment with FDA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback